 Shares of BioDelivery Sciences International Inc. BDSI, -1.62 blasted 51.7 higher to pace all premarket gainers Monday, after the specialty pharmaceutical company with a portfolio of pain and neurology products agreed to be acquired by Collegium Pharmaceutical Inc. COLL, -0.23 in a deal valued at about 604 million. Collegiums stock was still inactive ahead of the open. 